Lederer & Associates Investment Counsel Pfizer Inc Transaction History

Lederer & Associates Investment Counsel

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$35.91 - $40.68 $70,024 - $79,326	-1,950 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $65,305 - $73,651	1,950 New	1,950 $70,000
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $157,044 - $224,382	-5,810 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $191,265 - $217,061	5,810 New	5,810 $228,000
Q3 2019 Oct 07, 2019	SELL	$32.49 - $42.13 $179,182 - $232,346	-5,515 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$37.5 - $41.2 $8,812 - $9,682	-235 Reduced 4.09%	5,515 $234,000
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $7,694 - $8,772	-200 Reduced 3.36%	5,750 $251,000
Q3 2018 Oct 22, 2018	BUY	$34.47 - $41.81 $7,066 - $8,571	205 Added 3.57%	5,950 $262,000
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $183,322 - $212,679	5,745 New	5,745 $204,000

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Lederer & Associates Investment Counsel with notifications on news.